Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Incremental cost-effectiveness ratio (ICER)
In healthcare, the change in the cost of using a certain therapeutic intervention compared to an alternative, divided by the change in the effects the intervention may have caused.
See also:
Cost-effective (healthcare economics)
Related terms
Concordance programme, Elective care, Utility (pharmacoeconomics), Health Care Financing Administration (HCFA) (US) , Return on equity (ROE), Organic growth/development, Adherence, Baseline, Economic value added (EVA) , Cost-effectiveness threshold (health economics), Risk analysis, General practitioner (GP), Economic evaluation, Demand curve, Gross Domestic Product (GDP),
COVID-19 Updates and Daily News
Featured jobs
- Senior Account Executive, Medical/ Brand Communications, London
-
Highly competitive salary
-
Consultant Dermatologist (Freelance)
-
£110-180ph
-
Senior Health Psychologist, London
-
Highly competitive salary
-
Head of Health Psychology, London
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Recognising HIV Vaccine Awareness Day
- Scientists discover new approach to treat brain tumours
- Boehringer Ingelheim’s pulmonary fibrosis treatment produces promising phase 2 data
- NICE recommends AstraZeneca’s Imfinzi for adults with non-small cell lung cancer
- Phase 3 trial of AstraZeneca and Avillion’s PT027 shows promise for asthma patients
- J&J appoints Thibaut Mongon as CEO designate of New Consumer Health Company
- Sanofi and Regeneron receive FDA approval for eosinophilic oesophagitis treatment
- AstraZeneca’s COVID-19 vaccine receives EMA approval for use as third-dose booster
- Positive CHMP opinion issued for PTC Therapeutics’ Upstaza
- Live Webinar: The Future of MedTech: Streamlined Clinical Data Collection & Management
- Medscape: Connect to the conversation
- A Medscape 4-part video interview series
- Roche shares new positive Ocrevus data for MS patients
- First trial of a vaccine against Alzheimer’s launches
- Bristol Myers Squibb releases positive trial results for plaque psoriasis treatment
- MHRA approves Infex Therapeutics’s study for treatment for non-cystic fibrosis patients
- Creating an engaging experience for patients
- Mapping patient pathways – with a focus on patient-centricity
PMHub
3 Monkeys Zeno
3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...
